References
- Tenover J L. Male hormone replacement therapy including ‘andropause’. Endocrinol Metab Clin Am 1998; 27: 969–87
- Snyder P J, Lawrence D A. Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 1980; 51: 969–87
- Jordan W P. Allergy, and topical irritation associated with transdermal testosterone administration: a comparison of scrotal, and nonscrotal transdermal systems. Am J Contact Dermat 1997; 8: 108–13
- Yu Z, Gupta S K, Hwang S S, et al. Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men. J Clin Pharmacol 1997; 37: 1139–45
- Dobs A S, Meikle A W, Arver S, et al. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84: 3469–78